Invivyd (IVVD) Set to Announce Earnings on Thursday

Invivyd (NASDAQ:IVVD) will be announcing its earnings results before the market opens on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Invivyd (NASDAQ:IVVD) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.37) by ($0.03). The company had revenue of $2.26 million for the quarter, compared to analysts’ expectations of $4.91 million. On average, analysts expect Invivyd to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Invivyd Stock Up 2.3 %

Shares of IVVD opened at $1.00 on Wednesday. The company has a 50 day moving average of $0.99 and a two-hundred day moving average of $1.32. Invivyd has a twelve month low of $0.81 and a twelve month high of $5.20. The company has a market cap of $119.44 million, a price-to-earnings ratio of -0.54 and a beta of 0.65.

Wall Street Analyst Weigh In

IVVD has been the subject of a number of recent analyst reports. EF Hutton Acquisition Co. I raised Invivyd to a “strong-buy” rating in a research report on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of Invivyd in a report on Tuesday, October 29th.

Invivyd Company Profile

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.